对二次性免疫缺陷疾病患者的促进皮下免疫球蛋白使用的见解:FIGARO子组分析

Maria Dimou1, Matthaios Speletas2, Cinzia Milito3

  • 1First Department of Propaedeutic Internal Medicine, National & Kapodistrian University of Athens Medical School, General Hospital "LAIKO", 11527 Athens, Greece.

Cancers
|September 28, 2023
PubMed
概括

促进皮下免疫球蛋白 (fSCIG) 是可行的,并且在患有二次免疫缺陷 (SID) 的患者中耐受良好. 这种疗法提供灵活的管理,包括老年人的家庭自我管理,具有良好的临床结果.

相关概念视频

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
970